How many investments has Amplitude Venture Capital made?

Amplitude Venture Capital has 11 tracked investments, 1 of which have exited, including 2 dated in the last 24 months.

What stage does Amplitude Venture Capital invest at?

Amplitude Venture Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.

What sectors does Amplitude Venture Capital focus on?

Amplitude Venture Capital focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.

Where is Amplitude Venture Capital located?

Amplitude Venture Capital is headquartered in Montreal, CA.

Does Amplitude Venture Capital lead rounds?

Amplitude Venture Capital typically participates in rounds rather than leading them.

Amplitude Venture Capital

Venture capitaloperating company · company profile

Montreal · Seed–Late Stage · 14 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Amplitude Venture Capital

2,979 people in our graph share verified history with the Amplitude Venture Capital team — schools, employers, funds. One of them is your warm intro.

Paul Kwanunlockedknows Allison Gaw · together at Stanford University (overlapped)

×3knows the team · via The Wharton School

×2knows the team · via Flagship Pioneering

knows the team · via Stanford University

×2knows the team · via Creative Destruction Lab

knows the team · via Panache Ventures

✨ Fox Verdict

Investment thesis

Amplitude focuses on human health from ideation through patient care, specializing in precision medicine. As active company builders, entrepreneurs, and scientists, the firm partners with founders to create, build, and scale biotech and health science companies. It emphasizes excellence, transparency, and integrity, working closely with founders on strategy, talent, and fundraising. Amplitude also runs the Amplitude Fellowship, a summer program bringing Canadian health-focused PhD candidates, post-docs, and MDs together to explore biotech concepts and launch new health science companies.

Invests inAI & Machine Learning Biotech Digital Health Healthtech Medical Devices Canada Global Montreal North America United States

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Late Stage

Montreal, QC, CA

Leads rounds

Follows

Instruments

Equity

Founded

2018

Last 12 months

1 investment

AUM

$340M

Tracked investments

IPOs

Team · 14 people

from the firm's website & public directories

Matthew Rosenberger· Partner, CFO· Canadain

Partner and CFO at Amplitude, overseeing finance, legal, and administrative operations including due diligence and portfolio analysis. Previously Director of Finance at CoPower, a cleantech fund. Holds a BCom from McGill, a CPA, and is a CFA Charterholder.

Allison Gaw· Partner· Greater Vancouver Metropolitan Areain

Partner with 20 years of life science and drug development experience; previously VP of Business Development at Chinook Therapeutics and Senior Director at Sierra Oncology, and a consultant at BCG and LEK.

a•••@amplitudevc.comreveal

Bharat Srinivasa· Partner· Toronto, Ontarioin 𝕏

Co-founder and Partner at Amplitude (since 2018) with 15+ years in life sciences across VC, consulting, and biotech R&D; has co-founded three companies, two as founding CEO. Previously on the Healthcare Venture Fund investment team at BDC Capital. Holds a PhD and MSc in immunology from McGill and a BSc from the University of Toronto.

b•••@amplitudevc.comreveal

Dion Madsen· Partner· Canadain 𝕏

Co-founder and Managing Partner at Amplitude (since 2018) with a career spanning startups and public companies as executive and investor across life sciences, healthcare, and other sectors. Previously Senior Managing Partner of the Healthcare Venture Fund at BDC Capital and held roles at RBC Capital Partners and Unilever's US corporate venture fund.

d•••@amplitudevc.comreveal

Jean-François Pariseau· Managing Partner· Montrealin 𝕏

Managing Partner who co-founded Amplitude in 2018; a former scientist turned entrepreneur with 25+ years in biopharma, digital, and medtech, previously building the life sciences practice at BDC Capital and CDPQ.

j•••@amplitudevc.comreveal

Evelyn Pau· Principal· Toronto, Ontario, Canadain

Principal at Amplitude (joined August 2024), working with portfolio companies and Pre-Amp's Venture Studio while supporting diligence and deal nomination. Previously VP, Investment Banking at Bloom Burton & Co. Holds a PhD in immunology from the University of Toronto.

Michael Mee· Principal· Montrealin 𝕏

Partner at Amplitude (joined 2019) and Managing Director of Pre-Amp, the firm's incubation engine. Previously built platform companies at Flagship Pioneering. Holds a BEng from McGill and a PhD in biomedical engineering from Boston University.

m•••@amplitudevc.comreveal

Nancy Harrison· Venture Partner· Vancouver, BCin

Venture Partner who joined Amplitude in 2020, with over 30 years in life sciences and both company-creation and VC experience, previously a Partner at Ventures West and co-founder/president of MSI Methylation Sciences.

n•••@amplitudevc.comreveal

Colton Strong· Analyst· Vancouver, British Columbia, Canadain

Analyst at Amplitude who joined after the firm's Fellowship Program. His PhD at UBC pioneered lipid nanoparticles to genetically modify platelets as cell therapy; holds three patents with expertise in drug delivery and cell/gene therapies. Earned a BSc in Immunology from McGill.

Karen N. Li· Manager, Marketing and Communications· Toronto, Ontario, Canadain

Marketing and Communications Manager at Amplitude (joined October 2025), leading brand communications, creative assets, and events. Previously led communications and event production at Bloom Burton & Co. Holds an Honours BA from the University of Toronto.

k•••@amplitudevc.comreveal

Riccardo Cardilli· Finance Director· Montreal, Quebec, Canadain

Finance Director at Amplitude since 2022, focused on building financial and administrative infrastructure for early-stage biotech companies; previously Shared Services Controller at CellCarta Biosciences and a senior auditor at EY Montreal.

Juliana Muñoz· Associate· Canadain 𝕏

j•••@amplitudevc.comreveal

Nadia Lachman· Investor· Calgary, Alberta, Canadain

Investor at Amplitude (joined 2024) with a background in retail pharmacy, clinical trial recruitment, and early-stage health startups across therapeutics, medical devices, and digital health, plus prior B2B SaaS venture investing. Holds a BSc, an MBT, and an MBA from the University of Calgary.

n•••@amplitudevc.comreveal

Anish Kaushal· Analyst· Canada𝕏

Founder mafia

3 people who came through Amplitude Venture Capital went on to found or lead other companies.

Bharat SrinivasaPartnerFounded Radiant Biotherapeutics Michael MeePrincipalFounded Sana Biotechnology Ali TehraniEntrepreneur in ResidenceFounded Zymeworks

What they invest in

from 5 of 11 portfolio companies

Biotech ×5Healthtech ×3Medical Devices ×3Deep Tech ×1

HQs:United States×3Canada×1

Investments · 11 tracked

founders shown can be your intro path

By year:2026 · 1 2024 · 2 2023 · 2 2022 · 2 2021 · 2 2019 · 1 2018 · 111 dated

Zymeworkszymeworks.com in 𝕏NASDAQ: ZYMENov 2019

Zymeworks is a biotechnology company that develops novel therapeutics for patients with difficult-to-treat diseases using its proprietary drug-development platforms and in-house R&D.

BiotechHealthtechVancouver, US

ALI TEHRANI(Executive Officer, Director)inGORDON NG(Executive Officer)NEIL KLOMPAS(Executive Officer)in SURJIT DIXIT(Executive Officer)inDAVID TUCKER(Executive Officer)Paul Moore(Chief Scientific Officer)in

Co-investorsBrace Pharma CTI Life Sciences Fund L.P.Lumira Ventures Nextech Invest WUTIF Capital

Fluid Biomedfluidbiomed.comSeries A · Dec 2024 · $27M

Fluid Biomed develops a bioresorbable polymer-based stent designed to treat brain aneurysms by diverting blood flow and reducing risk of stroke.

BiotechDeep TechHealthtechMedical DevicesCalgary, CA

Dr. John H. Wong(Co-founder & Chief Executive Officer)Dr. Alim P. Mitha(Co-founder, President & Chief Technology Officer)

Co-investorsAccelerate Fund LifeArc Ventures ShangBay Capital LLC Thin Air Labs UCeed Funds IAG Capital Partners

Mediar Therapeuticsmediartx.com inSeries B · Jan 2026 · $76M

Mediartx develops novel therapies for patients with fibrotic diseases.

BiotechMedical DevicesBoston, US

Rahul Ballal, PhD(CEO)Paul Yaworsky, PhD(CSO)in Rahul Ballal(Executive Officer, Director)inBrian Hubbard(Director)Stacey Brenner(Executive Officer)David de Graaf(Director)

Co-investorsAgent Capital Longwood Fund Mission Biocapital Novartis Venture Fund Ono Venture Investment, Inc.Pfizer Venture Investments +3 more

Radiant Biotherapeuticsradiantbio.com inSeed · Apr 2023 · $8M

Radiant Biotherapeutics develops a platform of therapeutic molecules called Multabodies that engage multiple disease targets simultaneously within a single engineered protein to treat cancer and infectious diseases.

BiotechMedical Devices

Arthur Fratamico(Executive Officer, Promoter)Deborah Geraghty, Ph.D.(President and Chief Executive Officer)

Co-investorsFACIT (Fight Against Cancer Innovation Trust)Toronto Innovation Acceleration Partners Bill & Melinda Gates Foundation

Reverbtxreverbtx.com inSeed · Nov 2023

Reverb Therapeutics develops immunotherapies built on its Amplify•R platform, which modulates the body's natural immune system using targeted molecules such as IL-15-directed compounds.

BiotechHealthtech

Co-investorsInBC Investment Corp.Thin Air Labs KdT Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Abdera TherapeuticsAbility biologicsCongruence TherapeuticsGiiant PharmaImagiaThryv Therapeutics

Exits · 1

1 IPOs

ZymeworksNASDAQ: ZYME

Portfolio news

latest coverage across their companies

Zymeworks (ZYME) Stock Looks Fully Valued Despite Its 205% Three Year Run

Zymeworks · finance.yahoo.com · Jul 1, 2026

Mediar Therapeutics Announces Oversubscribed $76 Million Series B Financing and Clinical Advancement of First-in-Class Fibrosis Portfolio

Mediar Therapeutics · prnewswire.com · Jan 7, 2026

Sidley Represents Radiant Biotherapeutics in US$35M Series A Financing | News | Sidley Austin LLP

Radiant Biotherapeutics · sidley.com · Nov 25, 2025

Frequently asked questions

How many investments has Amplitude Venture Capital made?: Amplitude Venture Capital has 11 tracked investments, 1 of which have exited, including 2 dated in the last 24 months.
What stage does Amplitude Venture Capital invest at?: Amplitude Venture Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What sectors does Amplitude Venture Capital focus on?: Amplitude Venture Capital focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
Where is Amplitude Venture Capital located?: Amplitude Venture Capital is headquartered in Montreal, CA.
Does Amplitude Venture Capital lead rounds?: Amplitude Venture Capital typically participates in rounds rather than leading them.

Images

Co-investors · 9

ShangBay Capital LLC

ShangBay Capital is a venture capital firm that invests in founders building disruptive companies addressing high, unmet clinical needs with novel ideas.

Both backed · 2

Fluid Biomed Mediar Therapeutics

Dimension Capital

Dimension is a multistage investment firm that partners with companies working at the intersection of science and compute.

Both backed · 1

Congruence Therapeutics

$1M – $10M

Venrock

Venrock is a venture capital firm investing across technology and healthcare, backing companies in fintech, developer infrastructure, life sciences, therapeutics, semiconductors, and consumer products.

$500K – $10M

OrbiMed

OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.

$1M – $75M

BDC Venture Capital

This is the Analysis and Research section of BDC (Business Development Bank of Canada), publishing studies, surveys and reports on issues affecting Canadian small and medium-sized businesses.

$365K – $25.6M

Versant Ventures

Versant Ventures operates in-house Discovery Engines staffed by multidisciplinary scientists in dedicated laboratory facilities to help launch new biotechnology companies alongside academic founders.

$250K – $5M

Domain Associates

Domain Associates is a venture capital firm founded in 1985 that invests in life sciences companies. The firm operates as a limited liability company.

$200K – $15M

Samsara BioCapital

Samsara BioCapital is an investment firm backing the development of transformative therapeutics for patients, bringing together scientists, physicians, drug developers, and business leaders to support next-generation therapeutic breakthroughs.

Pappas Capital

Pappas Capital is a life sciences venture capital firm that invests in and helps build companies developing next-generation life science products and technologies.

$100K – $6M

Firms observed investing alongside Amplitude Venture Capital, from public investor directories. Shared companies are the overlap with Amplitude Venture Capital's recorded portfolio.

Similar investors

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

DCVC (Data Collective)

DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.

$5M – $25M

Eight Roads Ventures

Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.

$5M – $30M

GV (Google Ventures)

GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.